Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
Clinical trial NCT03902080 · COMPLETED
Trial details
- NCT number
- NCT03902080
- Sponsor
- Urovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2023-06-15
- Enrollment
- 1105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.